Mitral valve prolapse - Treatment
Alternative Names
Barlow's syndrome; Floppy mitral valve; Myxomatous mitral valve; Billowing mitral valve; Systolic click-murmur syndrome; Prolapsing mitral leaflet syndrome
Treatment:
Most of the time, there are no (or few) symptoms, and treatment is not needed.
If you have severe mitral valve prolapse, you may need to stay in the hospital. Surgery to repair or replace the valve may be needed if you have severe mitral regurgitation or your symptoms get worse.
Antibiotics are given if there is a bacterial infection or risk of one.
Other drugs that may be prescribed are listed below:
Expectations (prognosis):
Mitral valve prolapse should not adversely affect your lifestyle. If the leaky valve becomes severe, your outlook may be similar to mitral regurgitation from any other cause.
Most of the time, the condition is harmless and does not cause symptoms. Symptoms that do occur can be treated and controlled with medicine or surgery. However, some irregular heart beats (arrhythmias) associated with mitral valve prolapse can be deadly.
Complications:
- Endocarditis -- valve infection
- Severe leaky mitral valve (regurgitation)
- Stroke
- Clots to other areas
- Irregular heart beats (arrhythmias), including atrial fibrillation
Calling your health care provider:
Call your health care provider if you have increasing amounts of chest discomfort, palpitations, or fainting spells. Also alert your health care provider if you have any long-term illnesses with fevers.
- Reviewed last on: 5/12/2008
- Larry A. Weinrauch, MD, Assistant Professor of Medicine, Harvard Medical School, and Private practice specializing in Cardiovascular Disease, Watertown, MA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
References
American College of Cardiology/American Heart Association: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the Management of Patients With Valvular Heart Disease). J Am Coll Cardiol. 2006; 48:1-148.
Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease -- native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):457S-82S.
Karchmer AW. Infective Endocarditis. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 8th ed. St. Louis, Mo: WB Saunders; 2007: chap. 63.